PT Medikaloka Hermina Tbk (IDX:HEAL)
Indonesia · Delayed Price · Currency is IDR 975.00
-5.00 (-0.51%)
May 22, 2026, 4:02 PM WIB
PT Medikaloka Hermina Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,224,273 | 7,133,538 | 6,717,179 | 5,784,086 | 4,901,810 | 5,869,014 | |
Revenue Growth (YoY) | 7.77% | 6.20% | 16.13% | 18.00% | -16.48% | 32.90% |
Cost of Revenue | 4,947,650 | 4,852,368 | 4,394,399 | 3,863,841 | 3,333,002 | 3,085,874 |
Gross Profit | 2,276,623 | 2,281,170 | 2,322,780 | 1,920,245 | 1,568,808 | 2,783,140 |
Selling, General & Admin | 1,086,404 | 1,054,406 | 1,010,733 | 877,739 | 850,882 | 946,678 |
Other Operating Expenses | -26,973 | -27,177 | -22,771 | -36,771 | -71,588 | -29,844 |
Operating Expenses | 1,349,137 | 1,312,637 | 1,263,276 | 1,102,775 | 980,864 | 1,018,100 |
Operating Income | 927,486 | 968,533 | 1,059,504 | 817,470 | 587,944 | 1,765,040 |
Interest Expense | -238,414 | -238,440 | -179,099 | -139,560 | -139,833 | -143,196 |
Interest & Investment Income | 22,955 | 26,281 | 28,029 | 31,978 | 32,548 | 23,232 |
EBT Excluding Unusual Items | 712,027 | 756,374 | 908,434 | 709,888 | 480,659 | 1,645,076 |
Gain (Loss) on Sale of Investments | - | - | - | 9 | -21 | 2,437 |
Gain (Loss) on Sale of Assets | 186 | 186 | 1,071 | 845 | 632 | 399 |
Asset Writedown | -1,234 | -1,678 | -2,356 | -349 | -1,182 | -1,419 |
Pretax Income | 710,979 | 754,882 | 907,149 | 710,393 | 480,088 | 1,646,493 |
Income Tax Expense | 190,327 | 205,918 | 218,020 | 151,109 | 101,315 | 355,852 |
Earnings From Continuing Operations | 520,652 | 548,964 | 689,129 | 559,284 | 378,773 | 1,290,641 |
Minority Interest in Earnings | -114,572 | -119,417 | -153,187 | -121,938 | -80,177 | -294,667 |
Net Income | 406,080 | 429,547 | 535,942 | 437,346 | 298,596 | 995,974 |
Net Income to Common | 406,080 | 429,547 | 535,942 | 437,346 | 298,596 | 995,974 |
Net Income Growth | -13.55% | -19.85% | 22.54% | 46.47% | -70.02% | 110.47% |
Shares Outstanding (Basic) | 15,121 | 15,124 | 14,842 | 14,501 | 14,464 | 14,705 |
Shares Outstanding (Diluted) | 15,121 | 15,124 | 14,842 | 14,713 | 14,714 | 14,909 |
Shares Change (YoY) | 0.80% | 1.90% | 0.88% | -0.01% | -1.31% | 0.16% |
EPS (Basic) | 26.86 | 28.40 | 36.11 | 30.16 | 20.64 | 67.73 |
EPS (Diluted) | 26.86 | 28.40 | 36.11 | 29.73 | 20.29 | 66.80 |
EPS Growth | -14.22% | -21.35% | 21.46% | 46.52% | -69.63% | 110.14% |
Free Cash Flow | -496,834 | -612,151 | -1,144,368 | -271,707 | -261,272 | 642,792 |
Free Cash Flow Per Share | -32.86 | -40.48 | -77.10 | -18.47 | -17.76 | 43.11 |
Dividend Per Share | - | - | 10.500 | 8.500 | 7.000 | 6.000 |
Dividend Growth | - | - | 23.53% | 21.43% | 16.67% | 20.00% |
Gross Margin | 31.51% | 31.98% | 34.58% | 33.20% | 32.01% | 47.42% |
Operating Margin | 12.84% | 13.58% | 15.77% | 14.13% | 11.99% | 30.07% |
Profit Margin | 5.62% | 6.02% | 7.98% | 7.56% | 6.09% | 16.97% |
Free Cash Flow Margin | -6.88% | -8.58% | -17.04% | -4.70% | -5.33% | 10.95% |
EBITDA | 1,933,108 | 1,767,031 | 1,742,834 | 1,457,621 | 1,137,579 | 2,195,538 |
EBITDA Margin | 26.76% | 24.77% | 25.95% | 25.20% | 23.21% | 37.41% |
D&A For EBITDA | 1,005,622 | 798,498 | 683,330 | 640,151 | 549,635 | 430,498 |
EBIT | 927,486 | 968,533 | 1,059,504 | 817,470 | 587,944 | 1,765,040 |
EBIT Margin | 12.84% | 13.58% | 15.77% | 14.13% | 11.99% | 30.07% |
Effective Tax Rate | 26.77% | 27.28% | 24.03% | 21.27% | 21.10% | 21.61% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.